UT-Houston Awarded $2.5 Million for Scleroderma Research
University of Texas Health Science Center at HoustonThe University of Texas-Houston has been awarded $2.5 million by the National Institute of Arthritis and Musculoskeletal and Skin Diseases to establish a Specialized Center of Research (SCOR) in scleroderma, a chronic, often fatal connective tissue disease. Headquartered in the UT-Houston Medical School division of rheumatology and clinical immuno-genetics, the center will conduct a wide range of investigations into the disease for which there is no known effective treatment or means of prevention.